Recombinant protein A as well as coding gene and application thereof

A recombinant protein, coding gene technology, applied in the application, genetic engineering, plant genetic improvement and other directions, can solve the problems of antibody variability, residual impurities, and high ligand shedding rate, to improve adsorption performance, improve tolerance, The effect of prolonged tolerance

Inactive Publication Date: 2016-11-16
湖北爱晟生物科技有限公司
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to provide a recombinant protein A and its Coding genes and applications

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant protein A as well as coding gene and application thereof
  • Recombinant protein A as well as coding gene and application thereof
  • Recombinant protein A as well as coding gene and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] The optimization of embodiment 1 protein A gene

[0018] Such as figure 1 As shown, based on the analysis of the amino acid structure of natural protein A, the amino acid structure of natural protein A can be divided into five highly homologous amino acid regions, namely E, D, A, B, and C, and each region has about 50 amino acids , especially the B domain, which has the highest homology. Many reports believe that the B domain is the key region for antibody binding. Many modifications are based on the B domain, but our modification and transformation, first, the two-amino acid helical structure is based on the B structure At the same time, 8 glycine sequences are added at the back, which are connected to the third helical domain as a connecting segment, which reduces the direct steric hindrance of the three helices and improves the adsorption performance. The third helix takes the C domain and modifies it.

[0019] In the amino acid sequence of protein A, each domain i...

Embodiment 2

[0022] The expression of embodiment 2 recombinant protein A

[0023] The above-mentioned synthesized genes were respectively constructed into vectors, cultivated, expressed and purified to obtain recombinant protein A1 solutions, recombinant protein A2 solutions, recombinant protein A3 solutions, and recombinant protein A4 solutions whose sequences corresponded to SEQ ID NO: 1-4.

[0024] The expression vector is PET23a, and a single recombinant plasmid is transformed into Escherichia coli RosettaBlue (DE3) pLysS for fermentation and expression in LB liquid medium. After fermentation, the bacteria are collected and the cell wall is destroyed by thermal cracking to release the expression product out and centrifuge.

[0025] Purify the separation liquid through the IgG affinity medium, load the separation liquid through the affinity medium, wash the medium with 10mM phosphate buffer solution, collect the target protein with a buffer solution of pH 3.8, and adjust it to a neutral...

Embodiment 3

[0026] Example 3 Recombinant Protein A Preparation of Antibody Drug Purification Filler

[0027] Recombinant protein A adsorption microspheres 1 to 4 were respectively prepared by using the recombinant proteins A1 to A4 expressed in Example 2, and the preparation process was as follows:

[0028] 1) Microsphere activation

[0029] Bio-sep-6FF is cleaned with purified water, drained in a sand core funnel, weighed 10g of microspheres, 20ml of purified water, 0.2g of sodium hydroxide, 10ml of epichlorohydrin, reacted in a 100ml Erlenmeyer flask, 30°C , 120rpm, reacted in a constant temperature oscillator for 5h, and completed the modification and activation of epichlorohydrin.

[0030] 2) Coupling

[0031] In a 100ml Erlenmeyer flask, add 80ml of recombinant protein A solution (10mg / ml), add activated microspheres 6FF10g, and then add Na 2 CO 3 10mg, KCL 200mg, (NH 4 ) 2 SO 4 500mg, NaOH 400mg, in a constant temperature oscillator, 37°C, 180rpm, 8h, then collect the micro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a recombinant protein A as well as a coding gene and application thereof. A coding gene of a natural protein A is modified so that the expression quantity of a coded recombinant protein A is remarkably improved; the modified recombinant protein has certain tolerance on extreme conditions including alkaline conditions, protease and the like. With the adoption of an adsorbent prepared from the recombinant protein, the adsorption property on an antibody is improved and the static adsorption property on human IgG can reach 50mg / g to 60mg / g; meanwhile, the tolerance on the alkaline conditions is improved and the tolerance time is prolonged under the condition of 0.1mol / L to 0.5mol / L.

Description

technical field [0001] The invention relates to a recombinant protein A and its coding gene and application, belonging to the field of biotechnology. Background technique [0002] Antibody drugs include protein drugs containing antibody gene fragments, which can specifically bind to target antigens, and have the advantages of high disease treatment effect and high safety. They are used in tumor diseases, cardiovascular diseases, especially It is a gradually important role in the treatment of autoimmune diseases, and it is a class of drugs with the highest growth rate among biological drugs, and plays an important role in the field of biopharmaceuticals. [0003] According to statistics from the Biochemical Database, the global scale of monoclonal antibodies was only US$20 billion in 2006, but it reached US$98 billion in 2015. During the preparation of monoclonal antibody drugs, the capture stage of antibodies plays an important role in the purification process of antibodies....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/31C12N15/31B01J20/24B01J20/28B01J20/30
CPCC07K14/31B01J20/24B01J20/28021
Inventor 韩振伟宋炜卢晅张雨成
Owner 湖北爱晟生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap